Will This Billion-Dollar Acquisition Be a Smart Move for Merck?
Merck recently completed its acquisition of a California-based biotech company.
Stay updated with breaking news from Imago Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Merck recently completed its acquisition of a California-based biotech company.
The deal marks Malaysia-based Xeraya's exit from the biopharma firm.
EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions.
Merck & Co Inc to buy Imago Biosciences in a $1.35 billion deal. Imago Biosciences stock opened more than 100% up on Monday.
Fred Hutchinson Cancer Center lung cancer scientists open a human trial after preclinical work shows that making small cell lung cancer more visible to immune cells can make the tumors more responsive to immunotherapy.